Last edition
News about "Catalyst Pharmaceuticals "
Aurobindo Pharma Gets US FDA Approval for Perampanel Tablets
Aurobindo Pharma has received US FDA final approval for Perampanel Tablets, 2 mg to 12 mg, equivalent to Fycompa Tablets.
Catalyst Pharmaceuticals | 06/10/2026 | By News Bureau | 197
Catalyst Pharmaceuticals Announces Launch of FIRDAPSE in Japan by DyDo
FIRDAPSE (amifampridine) is the only US FDA approved, evidence-based therapy for the treatment of LEMS in adults and pediatric patients six years of age and older.
Catalyst Pharmaceuticals | 22/01/2025 | By Aishwarya | 565
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy